SCHEMBL18308332

SCHEMBL18308332

COc1cc2c(cc1/C(C(C)=N)=C(\C)O)ncc1nnc(Cc3ccc(C#N)cc3)n12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIT P10721 1/20 0.35
▸ PRKDC P78527 7/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ CCR5 P51681 1/20 0.32
▸ PDE4A P27815 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4C Q08493 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ POLB P06746 1/20 0.31
▸ IDH1 O75874 2/20 0.31
▸ PLK1 P53350 1/20 0.31
▸ CACNA1G O43497 1/20 0.31
▸ CACNA1B Q00975 1/20 0.31
▸ MET P08581 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ MAP2K1 Q02750 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308508 0.92 KIT (0.38) KITPRKDCPLK1MET
SCHEMBL18308329 0.86 PLK1 (0.36) PRKDCIDH1PLK1MET
SCHEMBL18308371 0.83 MAP2K1 (0.35) KITPRKDCIDH1MAP2K1
SCHEMBL18308342 0.82 PDE2A (0.36) ALDH1A1GAASMN1; SMN2PLK1MET
SCHEMBL18308511 0.82 MRGPRX4 (0.40) NPSR1SMN1; SMN2
SCHEMBL18308550 0.82 HPGDS (0.31) —
SCHEMBL18308506 0.80 ALDH1A1 (0.37) NPSR1ALDH1A1SMN1; SMN2POLBPLK1
SCHEMBL18308352 0.78 EGFR (0.42) KITPDE4BMAP2K1
SCHEMBL18308388 0.78 CASP3 (0.35) ALDH1A1GAASMN1; SMN2TSHRPDE4A
SCHEMBL18308373 0.71 CSF1R (0.37) KITIDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016199943-A1 HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-12-15 — — WO disclosed
Send feedback